Plain-English translation of NCT07337161 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer, faster type of radiation therapy called stereotactic radiation works as well as standard radiation for people who have had surgery for advanced skin cancer (squamous cell carcinoma) in the head and neck area that has spread to lymph nodes. In the standard approach, radiation is given daily over 4 to 6.5 weeks. The new approach delivers radiation in just 5 treatments over 1 to 2 weeks using a more precise, focused beam. The trial will compare how well both approaches prevent cancer from coming back and how they affect patients' quality of life.
After surgery for advanced skin cancer with lymph node involvement, radiation therapy helps prevent recurrence, but standard treatment requires weeks of daily visits. This trial exists to see whether a much shorter radiation schedule can achieve the same cancer control with potentially fewer side effects and less disruption to patients' lives.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either standard radiation (daily treatments over 4 to 6.5 weeks) or the faster stereotactic radiation (5 treatments over 1 to 2 weeks). You will have imaging and planning visits before treatment begins, then attend your assigned radiation appointments. Throughout the trial and for 2 years after treatment, you will complete questionnaires about your symptoms and quality of life, and your doctors will monitor you for any side effects and signs of cancer recurrence.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Canada